Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Donald S. Wood, PhD, president and CEO of the Muscular Dystrophy Association (MDA). Their conversation focuses on the latest therapies for Duchenne muscular dystrophy and spinal muscular atrophy and on the upcoming 2022 MDA Clinical & Scientific Conference.
Read the full story: MDA 2022 Conference to Focus on Promising Therapies for SMA, DMD
